|
|
|
市场调查报告书
胰岛素给药设备:全球开发平台分析机会评估及与到2017年为止的市场预测
Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
| 出版商 |
GlobalData |
| 出版日期 |
2012年01月 |
商品编码 |
227854 |
| 内容信息 |
英文 Pages: 104 |
| 价格 |
|
|
胰岛素给药设备:全球开发平台分析机会评估及与到2017年为止的市场预测 是由出版商GlobalData在2012年01月所出版的。
这份英文市场调查报告书包含Pages: 104 价格从美金3995起跳。
本报告提供全球胰岛素给药设备市场主要数据，提供信息与分析，市场情况，竞争情形，市场趋势，市场动态，技术趋势和主要企业简介等信息，为您概述为以下内容。
第1章 目录
第2章 简介
第3章 疾病概要:糖尿病
第4章 胰岛素给药设备:概要
- 市场区分
- 胰岛素笔
- 胰岛素帮浦
- 胰岛素注射器
- 传统胰岛素帮浦配件
- 胰岛素给药设备比较
第5章 胰岛素给药设备:全球市场特徵
- 收益实际成果 - 2003～2010年
- 收益预测 - 2010～2017年
- 主要趋势
- 市场动态
第6章 全球胰岛素给药设备市场:不同市场区隔分析
- 胰岛素笔的收益实际成果 - 2003～2010年
- 胰岛素笔的收益预测 - 2010～2017年
- 胰岛素帮浦的收益实际成果 - 2003～2010年
- 胰岛素帮浦的收益预测 - 2010～2017年
- 胰岛素注射器的收益实际成果 - 2003～2010年
- 胰岛素注射器的收益预测 - 2010～2017年
- 传统胰岛素帮浦配件的收益实际成果 - 2003～2010年
- 传统胰岛素帮浦配件的收益预测 - 2010～2017年
第7章 各国的胰岛素给药设备市场上收益(2003～2017年)
- 收益实际成果 - 美国:2003～2010年
- 收益预测 - 美国:2010～2017年
- 收益实际成果 - 加拿大:2003～2010年
- 收益预测 - 加拿大:2010～2017年
- 收益实际成果 - 英国:2003～2010年
- 收益预测 - 英国:2010～2017年
- 收益实际成果 - 德国:2003～2010年
- 收益预测 - 德国:2010～2017年
- 收益实际成果 - 法国:2003～2010年
- 收益预测 - 法国:2010～2017年
- 收益实际成果 - 义大利:2003～2010年
- 收益预测 - 义大利:2010～2017年
- 收益实际成果 - 西班牙:2003～2010年
- 收益预测 - 西班牙:2010～2017年
- 收益实际成果 - 日本:2003～2010年
- 收益预测 - 日本:2010～2017年
- 收益实际成果 - 中国:2003～2010年
- 收益预测 - 中国:2010～2017年
- 收益实际成果 - 印度:2003～2010年
- 收益预测 - 印度:2010～2017年
- 收益实际成果 - 澳洲:2003～2010年
- 收益预测 - 澳洲:2010～2017年
- 收益实际成果 - 巴西:2003～2010年
- 收益预测 - 巴西:2010～2017年
第8章 胰岛素给药设备的主要企业
- 主要企业
- Medtronic Inc.
- Novo Nordisk A/S
- Sanofi
- Eli Lilly and Company
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd. (Disetronic Medical Systems AG)
第9章 胰岛素给药设备:开发平台评估
- 各开发阶段的开发中产品:2011年
- 开发阶段及各领域的开发平台评估:2011年
第10章 胰岛素给药设备市场上策略性交易分析
第11章 附录
图表
Abstract
Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData's new report, "Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global insulin delivery devices market. The report provides market landscape, competitive landscape and market trends information on the insulin delivery devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market's dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.
- Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints within the insulin delivery devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Novo Nordisk, Sanofi, Eli Lilly and Company, Becton, Dickinson and Company and F. Hoffmann-La Roche Ltd.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the insulin delivery devices globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What's the next big thing in the insulin delivery devices market landscape? - Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global insulin delivery devices market and the factors shaping it.
TOC
1 Table of Contents
1 Table of Contents 3
- 1.1 List of Tables 5
- 1.2 List of Figures 6
2 Introduction 8
- 2.1 GlobalData Report Guidance 8
3 Disease Overview - Diabetes 9
- 3.1 Types of Diabetes 9
- 3.1.1 Type 1 Diabetes 9
- 3.1.2 Type 2 Diabetes 9
- 3.1.3 Gestational Diabetes 9
- 3.2 Signs and Symptoms 9
- 3.3 Diagnosis 10
- 3.3.1 Fasting Plasma Glucose Test 10
- 3.3.2 Oral Glucose Tolerance Test 10
- 3.3.3 Random Plasma Glucose Test 10
- 3.4 Epidemiology 11
- 3.4.1 Epidemiology of Diabetes in the US 12
- 3.4.2 Epidemiology of Diabetes in the UK 12
- 3.4.3 Epidemiology of Diabetes in Japan 12
- 3.4.4 Epidemiology of Diabetes in India 12
- 3.4.5 Epidemiology of Diabetes in China 12
4 Insulin Delivery Devices - Overview 13
- 4.1 Insulin Delivery Devices, Market Segmentation 13
- 4.1.1 Insulin Pen 13
- 4.1.2 Insulin Pump 14
- 4.1.3 Insulin Syringe 14
- 4.1.4 Traditional Insulin Pump Accessories 14
- 4.2 Comparison of Insulin Delivery Devices 15
5 Insulin Delivery Devices - Global Market Characterization 16
- 5.1 Insulin Delivery Devices Market, Global, Revenue ($bn), Historic, 2003-2010 16
- 5.2 Insulin Delivery Devices Market, Global, Revenue ($bn), Forecast, 2010-2017 17
- 5.3 Global Insulin Delivery Devices Market, Key Trends 18
- 5.3.1 More People Use Insulin Pumps in the US than in European Countries, where Insulin Pens are the Preferred Choice 18
- 5.3.2 Disposable Insulin Pumps to Gain Market Share at the Expense of Traditional Insulin Pumps 18
- 5.3.3 Partnerships between Insulin Manufacturers and Insulin Delivery Devices Companies is a Recent Trend in the Insulin Delivery Devices Market 19
- 5.3.4 Food and Drug Administration to Tighten the Regulation of Infusion Pumps 20
- 5.3.5 Co-Marketing of Insulin Pumps with Blood Glucose Monitoring/Continuous Glucose Monitor Devices is a Recent Market Trend 21
- 5.3.6 Artificial Pancreas to be a Future Trend in the Insulin Pumps Market 21
- 5.4 Global Insulin Delivery Devices, Market Dynamics 24
- 5.4.1 Market Drivers 24
- 5.4.2 Market Restraints 27
6 Global Insulin Delivery Devices Market - Analysis by Segment 29
- 6.1 Insulin Pens, Global, Revenue ($m), Historic, 2003-2010 29
- 6.2 Insulin Pens, Global, Revenue ($m), Forecast, 2010-2017 30
- 6.2.1 Market Drivers 31
- 6.2.2 Market Restraints 33
- 6.3 Insulin Pumps, Global, Revenue ($m), Historic, 2003-2010 34
- 6.4 Insulin Pumps, Global, Revenue ($m), Forecast, 2010-2017 35
- 6.4.1 Market Drivers 36
- 6.4.2 Market Restraints 37
- 6.5 Insulin Syringes, Global, Revenue ($m), Historic, 2003-2010 38
- 6.6 Insulin Syringes, Global, Revenue ($m), Forecast, 2010-2017 39
- 6.6.1 Market Drivers 40
- 6.6.2 Market Restraints 40
- 6.7 Traditional Insulin Pump Accessories, Global, Revenue ($bn), History, 2003-2010 41
- 6.8 Traditional Insulin Pump Accessories, Global, Revenue ($bn), Forecast, 2010-2017 42
7 Insulin Delivery Devices Market - Analysis and Forecasts by Country, Revenue ($m), 2003-2017 43
- 7.1 Insulin Delivery Devices Market, The US, Revenue ($m), Historic, 2003-2010 43
- 7.2 Insulin Delivery Devices Market, The US, Revenue ($m), Forecast, 2010-2017 44
- 7.3 Insulin Delivery Devices Market, Canada, Revenue ($m), Historic, 2003-2010 45
- 7.4 Insulin Delivery Devices Market, Canada, Revenue ($m), Forecast, 2010-2017 46
- 7.5 Insulin Delivery Devices Market, The UK, Revenue ($m), Historic, 2003-2010 50
- 7.6 Insulin Delivery Devices Market, The UK, Revenue ($m), Forecast, 2010-2017 51
- 7.7 Insulin Delivery Devices Market, Germany, Revenue ($m), Historic, 2003-2010 52
- 7.8 Insulin Delivery Devices Market, Germany, Revenue ($m), Forecast, 2010-2017 53
- 7.9 Insulin Delivery Devices Market, France, Revenue ($m), Historic, 2003-2010 54
- 7.10 Insulin Delivery Devices Market, France, Revenue ($m), Forecast, 2010-2017 55
- 7.11 Insulin Delivery Devices Market, Italy, Revenue ($m), Historic, 2003-2010 56
- 7.12 Insulin Delivery Devices Market, Italy, Revenue ($m), Forecast, 2010-2017 57
- 7.13 Insulin Delivery Devices Market, Spain, Revenue ($m), Historic, 2003-2010 58
- 7.14 Insulin Delivery Devices Market, Spain, Revenue ($m), Forecast, 2010-2017 59
- 7.15 Insulin Delivery Devices Market, Japan, Revenue ($m), Historic, 2003-2010 60
- 7.16 Insulin Delivery Devices Market, Japan, Revenue ($m), Forecast, 2010-2017 61
- 7.17 Insulin Delivery Devices Market, China, Revenue ($m), Historic, 2003-2010 62
- 7.18 Insulin Delivery Devices Market, China, Revenue ($m), Forecast, 2010-2017 63
- 7.19 Insulin Delivery Devices Market, India, Revenue ($'000), Historic, 2003-2010 64
- 7.20 Insulin Delivery Devices Market, India, Revenue ($'000), Forecast, 2010-2017 65
- 7.21 Insulin Delivery Devices Market, Australia, Revenue ($m), Historic, 2003-2010 66
- 7.22 Insulin Delivery Devices Market, Australia, Revenue ($m), Forecast, 2010-2017 67
- 7.23 Insulin Delivery Devices Market, Brazil, Revenue ($m), Historic, 2003-2010 68
- 7.24 Insulin Delivery Devices Market, Brazil, Revenue ($m), Forecast, 2010-2017 69
8 Global Insulin Delivery Devices Market - Competitive Assessment 70
- 8.1 Insulin Delivery Devices Market, Global, Key Company Share (%), 2010 70
- 8.2 Insulin Delivery Devices, Global, Key Market Participants 71
- 8.2.1 Medtronic Inc. 71
- 8.2.2 Novo Nordisk A/S 73
- 8.2.3 Sanofi 75
- 8.2.4 Eli Lilly and Company 77
- 8.2.5 Becton, Dickinson and Company 78
- 8.2.6 F. Hoffmann-La Roche Ltd. (Disetronic Medical Systems AG) 80
9 Insulin Delivery Devices - Pipeline Assessment 81
- 9.1 Insulin Delivery Devices, Pipeline Products by Stage of Development, 2011 81
- 9.2 Pipeline Assessment by Developmental Stage and Territory, 2011 82
- 9.2.1 Insulin Pumps, Pipeline Assessment by Developmental Stage, 2011 82
- 9.2.2 Key Pipeline Products, Insulin Pumps 84
- 9.2.3 Insulin Pens, Pipeline by Developmental Stage and Territory, 2011 92
- 9.2.4 Key Pipeline Products, Insulin Pens 92
- 9.2.5 Insulin Syringes, Pipeline by Developmental Stage and Territory, 2011 93
- 9.2.6 Other Insulin Delivery Devices, Pipeline by Developmental Stage and Territory, 2011 93
- 9.2.7 Key Pipeline Products, Other Insulin Delivery Devices 94
10 Global Insulin Delivery Devices Market - Strategic Deals Analysis 96
- 10.1 Key Deals, Insulin Delivery Devices Market 96
- 10.1.1 Haselmeier Enters into Distribution Agreement with Biocon 96
- 10.1.2 Cellnovo Enters into Technology Integration Agreement with LifeScan 96
- 10.1.3 Insulet Announces Acquisition of Neighborhood Diabetes 97
- 10.1.4 Insulet Enters into Distribution Agreement with GlaxoSmithKline 97
- 10.1.5 Cellnovo Enters into Agreement with Home Diagnostics 97
- 10.1.6 Roche Holding Acquires Medingo from Elron Electronic Industries 97
- 10.1.7 JDRF Enters into Agreement with Becton, Dickinson and Company 98
- 10.1.8 Insulet Enters into Distribution Agreement with Ypsomed Holding 98
11 Appendix 99
- 11.1 Market Definitions 99
- 11.1.1 Insulin Delivery Devices 99
- 11.2 Abbreviations 100
- 11.3 Research Methodology 102
- 11.3.1 Secondary Research 102
- 11.3.2 Primary Research 102
- 11.3.3 Models 103
- 11.3.4 Forecasts 103
- 11.3.5 Expert Panel 103
- 11.4 GlobalData Consulting 103
- 11.5 Contact Us 103
- 11.6 Disclaimer 104
- 11.7 Sources 104
List of Tables
1.1 List of Tables
- Table 1: Fasting Plasma Glucose Test 10
- Table 2: Oral Glucose Tolerance Test 10
- Table 3: Oral Glucose Tolerance Test for Gestational Diabetes 10
- Table 4: Diabetes Prevalence (%) and Patient Population, by Country, 2011 11
- Table 5: Insulin Delivery Devices Market, Global, Revenue ($bn), 2003-2010 16
- Table 6: Insulin Delivery Devices Market, Global, Revenue ($bn), 2010-2017 17
- Table 7: Insulin Pumps Market, Global, 2006-2010 19
- Table 8: Organizations/Companies Developing Artificial Pancreas 22
- Table 9: Annual Increase in the Incidence of Diabetes Among Children in Europe, 1983-2005 24
- Table 10: Studies Indicating Safety and Efficacy of Insulin Pumps 25
- Table 11: Studies Suggesting Higher Risk of Ketoacidosis from Insulin Pump Use, 2004 and 2009 27
- Table 12: Insulin Pens, Global, Revenue ($m), 2003-2010 29
- Table 13: Insulin Pens, Global, Revenue ($m), 2010-2017 30
- Table 14: Studies Suggesting Advantages of Insulin Pens Over Insulin Syringes, 2008-2011 31
- Table 15: Studies Suggesting Better Patient Compliance with Insulin Pens than Insulin Syringes, 2007-2010 33
- Table 16: Insulin Pumps, Global, Revenue ($m), 2003-2010 34
- Table 17: Insulin Pumps, Global, Revenue ($m), 2010-2017 35
- Table 18: Studies Indicating Safety and Efficacy of Insulin Pump Therapy in Pregnant Women, 2001-2011 36
- Table 19: Insulin Syringes, Global, Revenue ($m), 2003-2010 38
- Table 20: Insulin Syringes, Global, Revenue ($m), 2010-2017 39
- Table 21: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2003-2010 41
- Table 22: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2010-2017 42
- Table 23: Insulin Delivery Devices Market, The US, Revenue ($m), 2003-2010 43
- Table 24: Insulin Delivery Devices Market, The US, Revenue ($m), 2010-2017 44
- Table 25: Insulin Delivery Devices Market, Canada, Revenue ($m), 2003-2010 45
- Table 26: Insulin Delivery Devices Market, Canada, Revenue ($m), 2010-2017 46
- Table 27: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of <$15,000, June 2011 47
- Table 28: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $43,000, June 2011 48
- Table 29: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $75,000, June 2011 49
- Table 30: Insulin Delivery Devices Market, The UK, Revenue ($m), 2003-2010 50
- Table 31: Insulin Delivery Devices Market, The UK, Revenue ($m), 2010-2017 51
- Table 32: Insulin Delivery Devices Market, Germany, Revenue ($m), 2003-2010 52
- Table 33: Insulin Delivery Devices Market, Germany, Revenue ($m), 2010-2017 53
- Table 34: Insulin Delivery Devices Market, France, Revenue ($m), 2003-2010 54
- Table 35: Insulin Delivery Devices Market, France, Revenue ($m), 2010-2017 55
- Table 36: Insulin Delivery Devices Market, Italy, Revenue ($m), 2003-2010 56
- Table 37: Insulin Delivery Devices Market, Italy, Revenue ($m), 2010-2017 57
- Table 38: Insulin Delivery Devices Market, Spain, Revenue ($m), 2003-2010 58
- Table 39: Insulin Delivery Devices Market, Spain, Revenue ($m), 2010-2017 59
- Table 40: Insulin Delivery Devices Market, Japan, Revenue ($m), 2003-2010 60
- Table 41: Insulin Delivery Devices Market, Japan, Revenue ($m), 2010-2017 61
- Table 42: Insulin Delivery Devices Market, China, Revenue ($m), 2003-2010 62
- Table 43: Insulin Delivery Devices Market, China, Revenue ($m), 2010-2017 63
- Table 44: Insulin Delivery Devices Market, India, Revenue ($'000), 2003-2010 64
- Table 45: Insulin Delivery Devices Market, India, Revenue ($'000), 2010-2017 65
- Table 46: Insulin Delivery Devices Market, Australia, Revenue ($m), 2003-2010 66
- Table 47: Insulin Delivery Devices Market, Australia, Revenue ($m), 2010-2017 67
- Table 48: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003-2010 68
- Table 49: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010-2017 69
- Table 50: Insulin Delivery Devices Market, Global, Key Company Revenue ($m), 2010 70
- Table 51: Pipeline Products, Medtronic Inc. 72
- Table 52: Key Insulin Delivery Products, Medtronic Inc. 73
- Table 53: Key Insulin Delivery Products, Novo Nordisk A/S 75
- Table 54: Key Insulin Delivery Products, Sanofi 76
- Table 55: Key Insulin Delivery Products, Eli Lilly and Company 78
- Table 56: Insulin Delivery Devices, Becton, Dickinson and Company 79
- Table 57: Key Insulin Delivery Products, Becton, Dickinson and Company 79
- Table 58: Key Insulin Delivery Products, Disetronic Medical Systems AG 80
- Table 59: Insulin Delivery Devices, Pipeline Products by Stage of Development, 2011 81
- Table 60: Insulin Pumps, Pipeline by Developmental Stage and Territory, 2011 82
- Table 61: Artificial Pancreas System (Boston University), Clinical Trial Details 84
- Table 62: Artificial Pancreas System (University of Virginia), Clinical Trial Details 87
- Table 63: Paradigm Veo System, Clinical Trial Details 90
- Table 64: Insulin Pens, Pipeline by Developmental Stage and Territory, 2011 92
- Table 65: NovoPen Echo, Clinical Trial Details 92
- Table 66: Insulin Syringes, Pipeline by Developmental Stage and Territory, 2011 93
- Table 67: Other Insulin Delivery Devices, Pipeline by Developmental Stage and Territory, 2011 93
- Table 68: AFREZZA - Medtone Inhaler, Clinical Trial Details 94
- Table 69: Key Deals, Insulin Delivery Devices Market, 2009-2011 96
List of Figures
1.2 List of Figures
- Figure 1: Diabetes Prevalence (%), Global, 2011 11
- Figure 2: Insulin Delivery Devices, Market Segmentation 13
- Figure 3: Comparison of Insulin Delivery Devices 15
- Figure 4: Insulin Delivery Devices Market, Global, Revenue ($bn), 2003-2010 16
- Figure 5: Insulin Delivery Devices Market, Global, Revenue ($bn), 2010-2017 17
- Figure 6: Insulin Pumps Market, Global, 2006-2010 18
- Figure 7: Partnerships between Insulin Manufacturers and Insulin Delivery Device Companies 19
- Figure 8: Partnerships between Insulin Manufacturers and Insulin Delivery Device Companies 21
- Figure 9: Global Insulin Delivery Devices, Market Dynamics 24
- Figure 10: Causes of Type 1 Diabetes in Children 25
- Figure 11: Insulin Pens, Global, Revenue ($m), 2003-2010 29
- Figure 12: Insulin Pens, Global, Revenue ($m), 2010-2017 30
- Figure 13: Patient Perception Analysis for Insulin Pens and Insulin Syringes 32
- Figure 14: Insulin Pumps, Global, Revenue ($m), 2003-2010 34
- Figure 15: Insulin Pumps, Global, Revenue ($m), 2010-2017 35
- Figure 16: Insulin Syringes, Global, Revenue ($m), 2003-2010 38
- Figure 17: Insulin Syringes, Global, Revenue ($m), 2010-2017 39
- Figure 18: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2003-2010 41
- Figure 19: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2010-2017 42
- Figure 20: Insulin Delivery Devices Market, The US, Revenue ($m), 2003-2010 43
- Figure 21: Insulin Delivery Devices Market, The US, Revenue ($m), 2010-2017 44
- Figure 22: Insulin Delivery Devices Market, Canada, Revenue ($m), 2003-2010 45
- Figure 23: Insulin Delivery Devices Market, Canada, Revenue ($m), 2010-2017 46
- Figure 24: Individual Out-of-Pocket Expenses for Diabetes Management in Canadian Provinces with Annual Income of <$15,000, June 2011 47
- Figure 25: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $43,000, June 2011 48
- Figure 26: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $75,000, June 2011 49
- Figure 27: Insulin Delivery Devices Market, The UK, Revenue ($m), 2003-2010 50
- Figure 28: Insulin Delivery Devices Market, The UK, Revenue ($m), 2010-2017 51
- Figure 29: Insulin Delivery Devices Market, Germany, Revenue ($m), 2003-2010 52
- Figure 30: Insulin Delivery Devices Market, Germany, Revenue ($m), 2010-2017 53
- Figure 31: Insulin Delivery Devices Market, France, Revenue ($m), 2003-2010 54
- Figure 32: Insulin Delivery Devices Market, France, Revenue ($m), 2010-2017 55
- Figure 33: Insulin Delivery Devices Market, Italy, Revenue ($m), 2003-2010 56
- Figure 34: Insulin Delivery Devices Market, Italy, Revenue ($m), 2010-2017 57
- Figure 35: Insulin Delivery Devices Market, Spain, Revenue ($m), 2003-2010 58
- Figure 36: Insulin Delivery Devices Market, Spain, Revenue ($m), 2010-2017 59
- Figure 37: Insulin Delivery Devices Market, Japan, Revenue ($m), 2003-2010 60
- Figure 38: Insulin Delivery Devices Market, Japan, Revenue ($m), 2010-2017 61
- Figure 39: Insulin Delivery Devices Market, China, Revenue ($m), 2003-2010 62
- Figure 40: Insulin Delivery Devices Market, China, Revenue ($m), 2010-2017 63
- Figure 41: Insulin Delivery Devices Market, India, Revenue ($'000), 2003-2010 64
- Figure 42: Insulin Delivery Devices Market, India, Revenue ($'000), 2010-2017 65
- Figure 43: Insulin Delivery Devices Market, Australia, Revenue ($m), 2003-2010 66
- Figure 44: Insulin Delivery Devices Market, Australia, Revenue ($m), 2010-2017 67
- Figure 45: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003-2010 68
- Figure 46: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010-2017 69
- Figure 47: Insulin Delivery Devices Market, Global, Key Company Share (%), 2010 70
- Figure 48: Insulin Delivery Devices Market, Competitive Assessment 71
- Figure 49: Insulin Delivery Devices, Pipeline Products by Stage of Development, 2011 81
- Figure 50: Insulin Pumps, Pipeline Assessment by Developmental Stage, 2011 82
胰岛素输送装置 - 糖尿病患病率的增加牵引了市场
2012年01月20日
环球讯息股份有限公司开始贩卖GlobalData所发行的报告书「Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 (胰岛素给药设备:全球开发平台分析机会评估及与到2017年为止的市场预测)」。
Globaldata推测2010年的全球胰岛素输送装置市场达到74亿美元规模。
糖尿病患病率大幅增加、胰岛素输送装置的偿还、以及肯定性临床结果让该同市场以复合年度成长率（CAGR）6%扩大、2017年预估可超过110亿美元
美国是最大的胰岛素输送装置市场、2010年市场规模为28亿美元。之后以CAGR 6%成长、2017年终将达到42亿美元。
这个成长的主要原因包含了所有年龄层中的糖尿病患病率增加、胰岛素帮浦的高市场浸透率、以及保险偿还制度等要因。
胰岛素帮浦，比起欧洲各国，在美国贝更一般性的使用著。
2010年5月所发行的Journal of Diabetes Science and Technology的记事中，胰岛素帮浦在美国的胰岛素输送中被利用较多，而在欧洲，常用的则是胰岛素笔。
Juvenile Diabetes Research Federation (JDRF)进一步提到了在美国，约有40万人的１型糖尿病患者在使用胰岛素笔。
|
 |
